Global comparison of cancer outcomes: standardization and correlation with healthcare expenditures.

ABSTRACT:

Background

Cancer outcomes vary widely among different countries. However, comparisons of cost-effectiveness and cost-efficiency of different systems are complex because the incidences of different cancers vary across countries and their chances of cure also differ substantially. We aim to propose a new standardized method for global comparison and to explore its relationship with economic indicators.

Methods

Cancer statistics from all 184 countries and 27 cancers listed in GLOBOCAN 2012 were analyzed. The complement of age-standardized mortality/incidence ratio [1 - (ASM/ASI)] was taken as the proxy relative survival (RS). Accounting for various country-specific cancer patterns, the cancer site-standardized proxy RS (proxy SS-RS) of individual countries were calculated by w

SUBMITTER: Choi HCW 

PROVIDER: S-EPMC6686500 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature